Physician profile
Wayne Cecil Levy
NPI 1679663538
$275,410.30
in general payments reported to CMS, 2019-2025
9 companies · $15K in 2025
The $15K reported for 2025 was more than what 81% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83K · 2020: $76K · 2021: $31K · 2022: $25K · 2023: $39K · 2024: $6,375 · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $56K · Honoraria: $2,500 · Travel and Lodging: $1,726 · Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $56,042.00 |
| Honoraria | $2,500.00 |
| Travel and Lodging | $1,725.72 |
| Food and Beverage | $157.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $179,763.80 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $34,680.17 | 2021-2025 | |
| Medtronic Vascular, INC. | $34,571.54 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $9,950.00 | 2023-2025 | Assure Wcd |
| Impulse Dynamics (USA) INC. | $9,225.00 | 2021-2025 | Optimizer, Optimizer |
| Livanova USA, INC. | $4,460.00 | 2023 | Vns - Vitaria |
| Zoll Respicardia, INC. | $2,759.79 | 2022-2023 | Remede System |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.